Mapping The Value Chain: SKU-Level Pricing Analysis Of Dental Membranes & Bone Grafts Across Key Regions
- Published: Nov, 2025
- Report ID: GVR-MT-100488
- Format: PDF/Excel databook
- No. of Pages/Datapoints: 60
- Report Coverage: 2024 - 2030
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Industry Dynamics, Trends and Scope
2.1. Industry Dynamics
2.1.1. Industry driver analysis
2.1.1.1. Rising prevalence of dental disorders
2.1.1.2. Technological advancements in biomaterials
2.1.1.3. Growing prevalence of dental disorders and tooth loss
2.1.1.4. Regional manufacturing and import costs
2.1.2. Industry restraint analysis
2.1.2.1. High product cost and limited affordability
2.1.3. Industry opportunity analysis
2.1.3.1. Rising Demand for Regenerative Dentistry
2.1.3.2. E-commerce and Digital Distribution Channels
2.1.3.3. Expansion in Emerging Markets
2.1.3.4. Growing Dental Implant Procedures
2.1.4. Industry challenge analysis
2.1.4.1. High Price Sensitivity Among End Users
2.1.4.2. Intense Competition and Product Differentiation
2.2. Industry Analysis Tools
2.2.1. Industry Analysis – Porter’s
2.2.1.1. Bargaining power of suppliers
2.2.1.2. Bargaining power of buyers
2.2.1.3. Threat of substitutes
2.2.1.4. Threat of new entrants
2.2.1.5. Competitive rivalry
2.2.2. PESTEL Analysis
2.2.2.1. Political & Legal Landscape
2.2.2.2. Economic and Social Landscape
2.2.2.3. Technological landscape
Chapter 3. Competitive Landscape
3.1. Recent Developments & Impact Analysis, By Key Market Participants
3.2. Company/Competition Categorization
3.2.1. Innovators
3.3. Vendor Landscape
3.3.1. List of key distributors and channel partners
3.3.2. Global Key company market share analysis, 2024
3.3.2.1. Dentsply Sirona
3.3.2.1.1. Company overview
3.3.2.1.2. Financial performance
3.3.2.1.3. Product benchmarking
3.3.2.1.4. Strategic initiatives
3.3.2.2. Neoss
3.3.2.2.1. Company overview
3.3.2.2.2. Financial performance
3.3.2.2.3. Product benchmarking
3.3.2.2.4. Strategic initiatives
3.3.2.3. Botiss
3.3.2.3.1. Company overview
3.3.2.3.2. Financial performance
3.3.2.3.3. Product benchmarking
3.3.2.3.4. Strategic initiatives
3.3.2.4. Advanced Medical Solutions Group plc
3.3.2.4.1. Company overview
3.3.2.4.2. Financial performance
3.3.2.4.3. Product benchmarking
3.3.2.4.4. Strategic initiatives
3.3.2.5. REGEDENT AG
3.3.2.5.1. Company overview
3.3.2.5.2. Financial performance
3.3.2.5.3. Product benchmarking
3.3.2.5.4. Strategic initiatives
3.3.2.6. Curasan AG
3.3.2.6.1. Company overview
3.3.2.6.2. Financial performance
3.3.2.6.3. Product benchmarking
3.3.2.6.4. Strategic initiatives
3.3.2.7. Advanced Medical Solutions Group plc
3.3.2.7.1. Company overview
3.3.2.7.2. Financial performance
3.3.2.7.3. Product benchmarking
3.3.2.7.4. Strategic initiatives
3.3.2.8. B&B Dental S.r.l
3.3.2.8.1. Company overview
3.3.2.8.2. Financial performance
3.3.2.8.3. Product benchmarking
3.3.2.8.4. Strategic initiatives
3.3.2.9. Institut Straumann AG
3.3.2.9.1. Company overview
3.3.2.9.2. Financial performance
3.3.2.9.3. Product benchmarking
3.3.2.9.4. Strategic initiatives
3.3.2.10. Nobel Biocare Services AG (Envista)
3.3.2.10.1. Company overview
3.3.2.10.2. Financial performance
3.3.2.10.3. Product benchmarking
3.3.2.10.4. Strategic initiatives
3.3.2.11. BioHorizons
3.3.2.11.1. Company overview
3.3.2.11.2. Financial performance
3.3.2.11.3. Product benchmarking
3.3.2.11.4. Strategic initiatives
3.3.2.12. ZimVie Inc.
3.3.2.12.1. Company overview
3.3.2.12.2. Financial performance
3.3.2.12.3. Product benchmarking
3.3.2.12.4. Strategic initiatives
3.3.2.13. Geistlich Holding
3.3.2.13.1. Company overview
3.3.2.13.2. Financial performance
3.3.2.13.3. Product benchmarking
3.3.2.13.4. Strategic initiatives
3.3.2.14. Medtronic
3.3.2.14.1. Company overview
3.3.2.14.2. Financial performance
3.3.2.14.3. Product benchmarking
3.3.2.14.4. Strategic initiatives
3.3.2.15. Bioteck S.p.A.
3.3.2.15.1. Company overview
3.3.2.15.2. Financial performance
3.3.2.15.3. Product benchmarking
3.3.2.15.4. Strategic initiatives
3.3.2.16. Osteogenics Biomedical (Envista)
3.3.2.16.1. Company overview
3.3.2.16.2. Financial performance
3.3.2.16.3. Product benchmarking
3.3.2.16.4. Strategic initiatives
3.3.2.17. Maxigen Biotech Inc..
3.3.2.17.1. Company overview
3.3.2.17.2. Financial performance
3.3.2.17.3. Product benchmarking
3.3.2.17.4. Strategic initiatives
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.